Latest filing published 06 Feb 2014 for STRATA Skin Sciences, Inc., €37k.
Insider track record
No signal scores available.
Closed purchases
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -79.8%Entry US$35.97 · Close at T+365 US$7.25
- -96.4%Entry US$445.00 · Close at T+365 US$16.06
- -96.4%Entry US$445.00 · Close at T+365 US$16.06
- -57.2%Entry US$39.00 · Close at T+365 US$16.68
- -47.8%Entry US$189.50 · Close at T+365 US$99.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Coradini: trading record in brief
Robert Coradini has filed trades across 2 companies (mainly through SEC (Form 4)), most often in WaferGen Bio-systems, Inc. and STRATA Skin Sciences, Inc. Over a trading history stretching from 7 July 2010 to 5 February 2014, the count stands at 21 filings.
Purchases make up the whole of the open-market record (12 purchases, €312k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants and 4 option exercises. Since January 2014: 1 purchase and no sales on the market.
Half of the purchases are above €9,390 and half below. After 10 purchases with a full 90-day history, the hit rate stands at 10% and the median 90-day move at -59.1%. This is a record of the past, not a forecast.
Most recently, on 6 February 2014, the filings show an open-market purchase worth €37k in STRATA Skin Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Coradini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 67,567 shares@ US$0.74Common StockSEC:0001209191-14-007896:0Canonical exit: 6 May 2014 (T+90)
- 70,218 sharesCommon StockSEC:0001140361-13-034656:0
- 62,500 sharesCommon StockSEC:0001140361-13-034656:1
- 15,000 shares@ US$0.99Common StockSEC:0001209191-13-034068:0Canonical exit: 26 Sept 2013 (T+90)
- 2,557 shares@ US$0.868Common StockSEC:0001209191-13-033931:0Canonical exit: 25 Sept 2013 (T+90)
- 1,200 shares@ US$0.867Common StockSEC:0001209191-13-033931:1Canonical exit: 25 Sept 2013 (T+90)
- 11,071 shares@ US$0.87Common StockSEC:0001209191-13-033931:2Canonical exit: 25 Sept 2013 (T+90)
- 172 shares@ US$0.869Common StockSEC:0001209191-13-033931:3Canonical exit: 25 Sept 2013 (T+90)
- 9,900 shares@ US$0.719Common StockSEC:0001209191-13-033325:0Canonical exit: 22 Sept 2013 (T+90)
- 40,000 shares@ US$0.72Common StockSEC:0001209191-13-033325:1Canonical exit: 22 Sept 2013 (T+90)
- 100 shares@ US$0.716Common StockSEC:0001209191-13-033325:2Canonical exit: 22 Sept 2013 (T+90)
- 10,000 shares0Common StockSEC:0001144204-12-000859:0
- 21,457 shares@ US$3.97Common StockSEC:0001209191-11-062519:0Canonical exit: 20 Mar 2012 (T+90)
- 1,250 shares0Common StockSEC:0001144204-11-054027:0
- 1,250 shares0Common StockSEC:0001144204-11-036618:0
- 1,250 shares0Common StockSEC:0001144204-11-015985:0
- 10,000 shares0Common StockSEC:0001144204-11-000888:0
- 1,250 shares0Common StockSEC:0001144204-10-067467:0
- 5,000 shares0Common StockSEC:0001144204-10-067467:1
- 125,000 shares@ US$1.20Common StockSEC:0001144204-10-037387:0Canonical exit: 5 Oct 2010 (T+90)
20 of 20 declarations
